Personality Disorders

April 12, 2018

This is a private course and registrations are not being accepted.

Target Audience

Primary care providers, clinical behavior health specialists, and behavior health directors.

Learning Objectives

  • Recognize clinical features of personality disorders.
  • Recommend appropriate treatment for each personality disorder.


Sarah Grady, Pharm D
Pharmacist, Broadlawns Medical Center, Associate Professor, Drake University 

Relevant to the content of this CME activity, Dr. Grady indicated she has no financial relationships with commercial interest companies to disclose.


  • Ripoll LH. Clinical Psychopharmacology of Borderline Personality Disorder. Curr Opin Psychiatry. 2012;25(1):52-58.
  • Ripoll LH et al. Evidence-based pharmacotherapy for personality disorders. International Journal of Neuropsychopharmacology. 2011;14(9)1257-88.
  • American Psychiatric Association: Practice guideline for treatment of patients with borderline personality disorder. Am J Psychiatry 2001;158:1-52.
  • Skodol et al. Dimensional representations of DSM-IV personality disorders: relationships to functional impairment. Am J Psychiatry. 2005;162:1919-25.
  • National Institute for Clinical Excellence (NICE): Borderline Personality Disorder: treatment & management, Clinical Guideline 78. January 2009.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credits
  • 1.00 AOA Category 2­A
  • 1.00 CE Contact Hour(s)
Course opens: 
Course expires: 
Event starts: 
04/12/2018 - 8:00am CDT
Event ends: 
04/12/2018 - 9:20am CDT

Continuing Education Credit

  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • MD:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and Primary Health Care, Inc. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
  • Other healthcare professionals: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)TM

Educational Grants

No commercial interest provided financial support for this continuing education activity.


Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.00 AMA PRA Category 1 Credits
  • 1.00 AOA Category 2­A
  • 1.00 CE Contact Hour(s)


Please login or Create an Account to take this course.